𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cholinergic Deficit and Response to Donepezil Therapy in Parkinson’s Disease with Dementia

✍ Scribed by Hiraoka, Kotaro; Okamura, Nobuyuki; Funaki, Yoshihito; Hayashi, Akiko; Tashiro, Manabu; Hisanaga, Kinya; Fujii, Toshikatsu; Takeda, Atsushi; Yanai, Kazuhiko; Iwata, Ren; Mori, Etsuro

Book ID
119985811
Publisher
S. Karger AG
Year
2012
Tongue
English
Weight
231 KB
Volume
68
Category
Article
ISSN
0014-3022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cholinergic and other neurotransmitter m
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
✍ Paul T. Francis; Elaine K. Perry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b

Cognitive, psychiatric and motor respons
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia
✍ D. Aarsland; M. Hutchinson; J. P. Larsen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

## Abstract ## Background Cholinesterase inhibitors with additional nicotinic activity, such as galantamine, may be useful in PD patients with dementia (PDD) since stimulation of nicotinic receptors may prevent the down‐regualation that is likely to accompany cholinesterase inhibition and facilita